Shockwave therapy and exercise for plantar heel pain: A pilot study

Not Applicable

• Conditions: Plantar fasciopathy; Musculoskeletal Diseases

• Registration Number: ISRCTN82762757
• Lead Sponsor: Robert Gordon University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-31
• Study Completion: 2020-06-01
• Last Update Posted: 4 October 2021

Recruitment & Eligibility

• Status: Stopped
• Sex: All
• Target Recruitment: 48

Inclusion Criteria

1. Adults over the age of 18
2. Diagnosis of plantar fasciopathy by referring clinician to include:
2.1 Heel Pain in the morning or after sitting for extended periods
2.2 Localised pain on palpation where the plantar fascia attaches to the heel – medial calcaneal tuberosity
2.3 Increased pain with walking or standing for extended periods
3. History of at least 3 months of heel pain prior to beginning trial
4. Willingness to abstain from any other treatments during the trial
5. Signed informed consent form

Exclusion Criteria

1. Neurological abnormalities, peripheral neuropathy or nerve entrapment syndromes (e.g., tarsal tunnel syndrome)
2. Infections or tumours of the lower extremity, active malignancy
3. Vascular abnormality (e.g., severe varicosities, ischaemia)
4. Arthrosis or arthritis of the foot, rheumatoid arthritis
5. Systemic inflammatory disease, osteomyelitis
6. Dysfunction of the foot or ankle (e.g. chronic instability)
7. Corticosteroid injection or shockwave therapy within 6 weeks of beginning trial interventions
8. Calcaneal stress fracture, plantar fascia rupture or previous surgery for heel spur or plantar fascia
9. Bleeding disorder or haemophilia or active coagulation therapy
10. Cardiac pacemaker
11. Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified